Immunostimulatory sequence oligodeoxynucleotide-based vaccination and immunomodulation: Two unique but complementary strategies for the treatment of allergic diseases
- 1 November 2002
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 110 (5) , 706-712
- https://doi.org/10.1067/mai.2002.129122
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Systemic or mucosal administration of immunostimulatory DNA inhibits early and late phases of murine allergic conjunctivitisEuropean Journal of Immunology, 2000
- 215 Immunostimulatory oligonucleotides conjugated to Amb a 1: Safety, skin test reactivity, and basophil histamine releaseJournal of Allergy and Clinical Immunology, 2000
- Immunostimulatory DNA and applications to allergic diseaseJournal of Allergy and Clinical Immunology, 1999
- DNA–Based Immunization for AsthmaInternational Archives of Allergy and Immunology, 1999
- Immunostimulatory DNA Is a Potent Mucosal AdjuvantCellular Immunology, 1998
- Role of interleukin 10 in specific immunotherapy.Journal of Clinical Investigation, 1998
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Synthetic Oligonucleotides with Certain Palindromes Stimulate Interferon Production of Human Peripheral Blood Lymphocytes in vitroJapanese Journal of Cancer Research, 1994
- In vitro Augmentation of Natural Killer Cell Activity and Production of Interferon‐α/β and ‐γ with Deoxyribonucleic Acid Fraction from Mycobacterium bovis BCGJapanese Journal of Cancer Research, 1988
- DNA methylation and the frequency of CpG in animal DNANucleic Acids Research, 1980